ClinicalTrials.gg
Not yet recruitingNCT07872787NURSE-GAUpdated Oct 14, 2026

NURSE-led Geriatric Assessment in Older Colorectal Cancer Patients

An interventional study of Nurse-led Geriatric Assessment in Colo-rectal Cancer, sponsored by Helse Stavanger HF. Not yet recruiting at 1 site in Norway. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Helse Stavanger HF · Not applicable, Interventional, and Health services research

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
70 Years and older
Sex
All
01

Study summary

Older colorectal cancer patients frequently present with frailty, comorbidity, and other age-related vulnerabilities that may affect treatment tolerance and outcomes. Geriatric assessment is recommended for older adults with cancer but remains underutilized. The NURSE-GA study aims to evaluate the feasibility of a nurse-led geriatric assessment intervention prior to treatment decision-making for patients aged 70 years and older who are newly diagnosed with colorectal cancer and have a Clinical Frailty Scale score of 4 or higher. Trained nurses will perform structured geriatric assessments and identify optimization needs and referral needs. The study will evaluate intervention delivery, patient satisfaction, clinical outcomes, usability among multidisciplinary team members, self-efficacy among nurses, and recruitment and retention rates.

Read the detailed description

Older adults with colorectal cancer represent a clinically heterogeneous population with varying levels of frailty, comorbidity, functional reserve, and treatment tolerance. Standard treatment decision-making often relies on performance status assessments that may not identify vulnerabilities relevant to treatment outcomes. Geriatric assessment is recommended in geriatric oncology to identify age-related health issues and support individualized treatment planning; however, implementation in routine clinical practice remains limited.

The NURSE-GA study evaluates the feasibility of integrating a structured nurse-led geriatric assessment into the preoperative colorectal cancer pathway. The intervention has been developed through a scoping review, expert consensus processes, and stakeholder involvement to support implementation in routine oncology practice.

The intervention is delivered by specially trained nurses and includes systematic assessment of health domains relevant to treatment tolerance among older adults. Assessment findings are used to identify optimization needs and referral requirements when indicated.

The study uses a mixed-methods feasibility design conducted in a surgical oncology outpatient setting. Quantitative and qualitative data will be collected to evaluate intervention delivery, study procedures, patient satisfaction, acceptability among healthcare professionals, and the feasibility of conducting a future larger-scale study.

02

Conditions studied

  • Colo-rectal Cancer

Keywords

  • geriatric assessment
  • nurse-led
  • frailty
  • colorectal cancer
  • older adults
  • surgical oncology
03

In context

Colonic Neoplasms

1,485 studies on the registry are indexed under Colonic Neoplasms; 362 are open to participants now.

This study's planned enrollment of 50 is below the median of 89 across 1,067 interventional studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

Helse Stavanger HF is the lead sponsor of 97 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 70 years or older
  • Newly diagnosed colorectal cancer
  • Clinical Frailty Scale score 4 or higher
  • Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Cancer treatment already initiated
  • Clinical Frailty Scale score 3 or less
  • Unable to understand, read, or speak Norwegian
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    NURSE-GA Intervention

    Participants aged 70 years and older with newly diagnosed colorectal cancer and a Clinical Frailty Scale score of 4 or higher and thus considered to require further assessment prior to treatment decision-making will receive the NURSE-GA intervention. The intervention consists of a structured nurse-led geriatric assessment performed before cancer treatment decisions are finalized.

    Behavioral: Nurse-led Geriatric Assessment

Interventions

  • BehavioralNurse-led Geriatric Assessment

    Patients are routinely screened using the Clinical Frailty Scale in the clinical cancer pathway. Patients identified as potentially frail are offered a structured nurse-led geriatric assessment delivered by trained nurses. The intervention includes a multidimensional geriatric assessment covering patient preferences, functional status, nutrition, cognition, psychological health, social support, and medication. In addition, the nurse identifies patient needs, and optimization measures may be initiated and referrals made to relevant healthcare professionals, including physiotherapists, dietitians, geriatricians, or other physicians. A summary report is provided to the multidisciplinary team before treatment decision-making.

06

What researchers measure

Primary outcomes

  1. Nurse self-efficacy assessed through qualitative interviews

    Nurses' self-efficacy will be explored through semi-structured qualitative interviews focusing on confidence in conducting geriatric assessments, interpreting assessment findings, communicating results, and integrating geriatric assessment into oncology care. Interview transcripts will be analyzed using qualitative content analysis. This qualitative outcome measure does not produce a numerical score; therefore, no minimum or maximum values apply.

    Time frame: Through study completion, an average of 1 year

  2. Intervention usability among healthcare professionals assessed through semi-structured interviews

    Participating healthcare professionals will be interviewed regarding their experiences with the intervention, including usability, acceptability, feasibility, and perceived value. Interview transcripts will be analyzed using qualitative content analysis. No quantitative scale or numerical score will be used.

    Time frame: Through study completion, an average of 1 year.

  3. Constructive support from health professionals

    Constructive Support from Health Professionals is an 11-item scale that assesses individuals' perceptions of support received from health care professionals, including doctors, nurses, and other health care personnel. Responses are recorded on a five-point Likert scale ranging from strongly agree to strongly disagree. Higher scores indicate greater perceived support from health care providers.

    Time frame: Approxematly 1 month after hospital discharge

Secondary outcomes

  1. Status of Geriatric Assessment in newly diagnosed elderly colorectal cancer patients

    Description of the geriatric assessment status of the target population. Baseline geriatric assessment will be conducted by trained nurses and will include assessment of frailty (Clinical Frailty Scale), functional status (Activities of Daily Living and Instrumental Activities of Daily Living), nutritional status (Mini Nutritional Assessment-Short Form), cognitive function (Mini-Cog), psychological health (Geriatric Depression Scale), sensory function (hearing and vision assessed through observation and open-ended questions), mobility (4-meter gait speed and open-ended questions regarding mobility), social support (open-ended questions), and self-reported health-related quality of life. Standardized training in geriatric assessment procedures will be provided to all participating nurses prior to study initiation.

    Time frame: Baseline

  2. Referrals to non-oncology interventions

    Referrals to other healthcare professionals

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2027, 15 months later.

Of 290 non-industry interventional studies with no phase under Colonic Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 60. This study's planned 15 months is below that.

Counting every sponsor, half of 300 studies reached it within 32 months; a quarter within 18 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 14, 2026
StartEst.
Sep 28, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2031
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872787
Lead sponsor
Helse Stavanger HF
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Sep 28, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2031 (estimated)
Last update
Oct 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion